# Commission Implementing Decision (EU) 2016/135 of 29 January 2016 postponing the expiry date of approval of flocoumafen, brodifacoum and warfarin for use in biocidal products for product-type 14 (Text with EEA relevance), Signature

Extent: E+W+S+N.I.

Done at Brussels, 29 January 2016.
For the Commission
The President
Jean-Claude Juncker

---
Source: https://www.legislation.gov.uk/eudn/2016/135/signature (the official version)
Page: https://openlegislation.uk/eu-decision-2016-135/signature
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.